Chemring Countermeasures USA Contract Awards
September 11, 2019 - Chemring Group is pleased to announce that its US based subsidiary, Chemring Countermeasures USA (“CCM USA”), has been awarded four contracts to supply countermeasures in support of the US Navy and US Air Force.
The first contract, which is for the manufacture and delivery of MJU-64/B infrared decoys for the US Navy, is valued at $4.2 million, and was awarded to CCM USA with a second year award option in 2020. Deliveries under this contract will be made in 2019, with all work to be performed at CCM USA’s facility in Chester Township, Pennsylvania.
The second contract is an $8.1 million delivery order against an existing $94 million three year Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which is for the manufacture and delivery of MJU-66 flares for the US Navy and US Air Force. Deliveries under this contract will be made in 2020, with all work to be performed at CCM USA’s facility in Chester Township, Pennsylvania.
The third contract is a three year IDIQ contract for the manufacture and delivery of MJU-53/B flares for the US Air Force, with a maximum value of $90 million. The first delivery order against this contract is expected shortly with deliveries being made in 2020. Deliveries under this IDIQ are expected to be completed by July 2023, with all work being performed at CCM USA’s facility in Toone, Tennessee.
The fourth contract is a five year IDIQ for manufacture and delivery of the MJU-52A/B BOL IR flare for the US Air Force F-15 ANG, with a maximum value of $25 million. The first delivery order against this contract is for $5.2 million with deliveries being made in 2020. All work under this contract will be performed at CCM USA’s facility in Chester Township, Pennsylvania.
Mick Ord, Group Chief Executive of Chemring, commented:
“These contracts demonstrate the continued confidence of the US Navy and Air Force in Chemring’s ability to develop and supply quality aircraft countermeasures, and it recognises our dedication to protecting our customers.
“These contracts also complete the required FY19 order intake in our Countermeasures segment and provide a strong platform for FY20. They are further evidence of the recovery, and our strengthening position, in the global countermeasures market and supports the Group’s investment in its facilities.”
